Quest Diagnostics DGX
NYSE DGX
$244.63 -0.37 (-0.15%)
As of: Aug 27, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Divestments (2013 - 2016)

Quest Diagnostics (DGX) posted Divestments of $25.0 million for Q4 2016, up 600.0% sequentially from -$5.0 million in Q3 2016.

Quest Diagnostics (DGX) Divestments (2013 - 2016) Analysis & Trends

Quest Diagnostics has reported Divestments for 2 years, with the latest figure at $25.0 million in Q4 2016.

  • Quarterly Divestments changed N/A year-over-year to $25.0 million in Q4 2016, while the trailing twelve-month figure through Sep 2020 was $25.0 million (changed N/A YoY) and the FY2021 annual result came in at $755.0 million, changed N/A from the prior year.
  • Divestments rose to $25.0 million in Q4 2016 per DGX's latest filing, from -$5.0 million in the prior quarter.
  • Over five years, Divestments peaked at $30.0 million in Q3 2013 and troughed at -$5.0 million in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -
10 Quest Diagnostics 27.10 Bn 26.47 Bn 1.03 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2016 25.00 Mn
Sep 30, 2016 -5.00 Mn
Sep 30, 2013 30.00 Mn